Navigation Links
Kenyan malaria success strengthens call for free insecticide-treated nets for all
Date:8/17/2007

Experts have today called for international agencies to provide insecticide-treated bed nets for all children in Africa as the most equitable way of tackling malaria. Their call is supported by new research co-funded by the Wellcome Trust showing how successful a scheme run by the Kenyan government has been at distributing the nets.

Over a million children die from malaria in Africa each year. Scientists have known for over 15 years that sleeping under a mosquito net treated with insecticide can halve the number of episodes of malaria and save lives. However, successful and equitable distribution of the nets has been difficult by the end of 2004, only 7% of children in rural Kenya were reported to sleeping under the nets and only 3% among the poorest sectors of these communities.

"Even when the price of a treated net is heavily subsidised and made more accessible through clinics, parents have to choose between school fees and food or a net," explains Professor Bob Snow from the Kenya Medical Research InstituteWellcome Trust (KEMRI-WT) Research Programme in Kenya, who led the research. "The result is that few children are protected. Those who can afford to protect their children tend to benefit most, but not those who cant."

In 2006 the Kenyan government initiated a programme to provide 3.4 million treated nets free to as many young children as possible in only two weeks. The nets were distributed at clinics, schools, vaccination points and by Ministry of Health staff walking from house-to-house . In this short period of time, coverage rose to two-thirds of all children sleeping under a treated net, with no difference between children from rich or poor homes. The results of the study to evaluate the initiative are published today in the open access journal PLoS Medicine.

However, despite the success of the Kenyan government's programme, Dr Abdisalan Mohamed Noor, lead author of the study, warns against complacency.

'/>"/>
Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Kenyan Children at Risk of Measles
2. Kenyan Women Six Times More Likely To Be HIV Positive Than Kenyan Men
3. Double Knee replacement for a Kenyan in Chennai
4. Improper Abortions- Kenyan Teenagers At Risk
5. Bio-latrine Cleans Up Kenyan Slum and the Environment
6. Kenyan Capital Bans Smoking in Public
7. Feeding channel created by malaria parasite - a new target for malaria treatments
8. Hundred million dollar gift for malaria institute
9. Malaria strikes Munger tribals
10. Sponging Cattle betters spraying in eradicating Malaria
11. Misleading anti-malarial drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Protect Investment And Restore Shareholder Value ...ire/ -- Dr. Stephen Joffe, Craig Joffe, and Alan B...3D with the U.S. Securities and Exchange Commissio...nership of 11.4% of LCA-Vision, Inc. (Nasdaq: LC... vision correction centers in 33 states in the Uni...
(Date:11/21/2008)...stCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL...ingly approved the proposals submitted to them rel...ticals Industries Ltd. (Nasdaq: TEVA ). , ,...pport of the transaction by the Barr shareholders,...We are pleased with the progress that we continue ...
(Date:11/21/2008)...atewide survey, 33 physicians credentialed to prac...erian Hospital of Dallas were honored by Texas Mo...rs ." , , Each year, the publishers of Tex... to survey more than 38,000 medical professionals ...edical care, which doctor would you choose?" Key ...
(Date:11/21/2008)...ope Research(TM), a revolutionary,biometric media...Measurement,announced today the appointment of t... research and development, business strategy and m...ents, who deliver a combined 60 years of experienc...er and Vice President of,Strategy; Dr. Ravi Kothu...
Breaking Medicine News(10 mins):Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...dministration ordered the makers of ADHD drugs to ...ients, the significant// ones being psychiatric an...or of the FDA’s Center for Drug Evaluation and Res... immensely useful in treating patients with ADHD, ...
... degeneration (AMD) is the leading cause of visual...50, affecting// more than two million people. Th...d people that although AMD is incurable, there are...sually recover lost vision and prevent further vis...
... safe and healthy multivitamin? Vitamins and Miner...ard Medical School//, offers the following advice....t bear the U.S. Pharmacopeia Dietary Supplement Ve... mark, which indicates that the manufacturer has c...
...dia has immensely deteriorated over the last seven...t victims//, top UNICEF officials said Wednesday. ...I, (NFHS-3), over 56.2 percent married women in th...49 were anemic in 2006 as against 51.8 percent in ...
Other Medicine News:Health News:Spring is Time for Age-Related Macular Degeneration (AMD) Awareness 2Health News:Married Women, Children Most Anemic in India 2
(Date:11/21/2008).../ -- Ikaria Holdings, Inc. today announced that it... New Jersey Technology Council (NJTC), a 1,200-mem... support, networking opportunities, information an...ers. Ikaria earned the award based on criteria inc...e provision. , , "We are delighted that the...
(Date:11/20/2008)...F FIRST PHASE III TRIAL SHOW SIGNIFICANT, DEC...LY FUNCTION, IN, FIBRO...SSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/,--...UCB (Euronext Brussels: UCB),announced today posi...f two,Phase III pivotal clinical trials of sodium...
(Date:11/20/2008)...ire/ -- Radius Health ("Radius") announced today t... second institutional financing round, increasing ... total amount raised since the company,s inception...estors participated in the financing, led by MPM B..., The Wellcome Trust, HealthCare Ventures, Oxford ...
(Date:11/19/2008)...Newswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) an...diary of,Takeda Pharmaceutical Company Limited (T... Phase 3 MONET1 trial evaluating motesanib (AMG 70... for the first-line treatment of,advanced non-sma...uspended,following a planned safety data review o...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Physicians Health Choice Hires Blue Clover as Agency of Record 26590 1Physicians Health Choice Hires Blue Clover as Agency of Record 26590 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 26586 1DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 26586 2Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 1Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 2Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 3Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 4Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 5
..., 2007 - Advanced Viral,Research Corp. (OTC Bullet...unced today that new information on AVR118 has bee... of the American,Society of Clinical Oncology (ASC...distributed to the nearly 25,000 oncology,praction...hicago on,June 1-5., Based on recent work conducte...
...s Across the Genome From 242,Patients and Identifi...astic Leukemia, Suggesting New Targets for Improve...ire/ -- Investigators at,St. Jude Children,s Resea...d mutations that contribute to the formation of pe...st common cancer in,children. The discovery not on...
Other Medicine Technology:American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 2American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 3Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
...ing tasks such as prescription writing, referral l...c. Your office will be ,able to add more appointme...ff., Based on the exam documentation created by th...ommend the appropriate E&M ,code for the visit - t...
... is an Electronic Medical Office (EMO) for the Oph... of your practice. In addition to retrieving and s...ically integrates the patient office flow includin... about patients, and billing information. ChartLog...
Access your patients' electronic medical records over the Internet with CardioChart. As a Web-enabled software application, physicians and clinicians can pull up a patient's cardiology and vascular m
... is a revolutionary Electronic Medical Office (EMO...stomized for the unique needs of your practice. Th...lectronic record system (EMR, EHR, and EPR), and t...fficiency and performance. In addition to retrievi...
Medicine Products: